Edgewise Therapeutics, Inc. (EWTX)
↓ Download CSVKey ratios (FY2025)
-32.1%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$191.41M | -$158.83M | -$114.36M | -$71.66M | -$43.22M | -$17.19M | — |
| Net Income | -$167.79M | -$133.81M | -$100.16M | -$67.64M | -$42.81M | -$17.12M | — |
| EPS (Diluted) | $-1.63 | $-1.45 | $-1.57 | $-1.26 | $-1.14 | $-23.17 | — |
| Total Assets | $552.60M | $486.82M | $340.04M | $367.10M | $285.23M | $131.14M | — |
| Total Liabilities | $30.35M | $27.60M | $21.20M | $20.39M | $10.85M | $4.34M | — |
| Shareholders' Equity | $522.26M | $459.22M | $318.83M | $346.72M | $274.38M | -$33.42M | -$16.85M |
| Cash & Equivalents | $61.15M | $41.67M | $86.10M | $21.99M | $15.57M | $104.92M | — |
| Operating Cash Flow | -$143.82M | -$109.03M | -$91.95M | -$52.63M | -$33.51M | -$14.63M | — |
| Capital Expenditures | $256.0K | $1.31M | $5.75M | $5.55M | $668.0K | $203.0K | — |
| Shares Outstanding | 106.25M | 94.84M | 70.45M | 63.26M | 49.50M | 1.01M | — |